Sopharma AD Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	22.14	36.63	18.3	65.89	10.15	19.29
Cash & Short-Term Investments	22.14	36.63	18.3	65.89	10.15	19.29
Cash Growth	-	100.16%	-72.23%	549.23%	-47.38%	49.20%
Accounts Receivable	248.86	219.63	144.22	143.07	121.33	123.81
Other Receivables	27.89	12.94	12.73	8.27	6.68	8.42
Receivables	276.76	238.23	162.87	157.86	132.26	133.15
Inventory	265.54	259.15	231.39	173.49	142.4	130.88
Prepaid Expenses	-	2.73	1.71	1.62	1.29	1.38
Restricted Cash	-	0	0.02	-	-	-
Other Current Assets	-	21.01	21.1	3.54	6.54	7.41
Total Current Assets	564.44	557.74	435.39	402.41	292.64	292.11
Property, Plant & Equipment	209.03	211.27	201.17	182.84	192.41	185.32
Long-Term Investments	151.17	148.16	135.42	120.27	85.68	68.06
Goodwill	2.8	2.81	2.84	1.76	1.8	6.86
Other Intangible Assets	125.48	127.32	131.88	29.57	24.61	27.83
Long-Term Deferred Tax Assets	9.24	6.82	0.59	1.44	1.05	0.54
Other Long-Term Assets	9.8	8.2	10.47	10.06	9.73	6.83
Total Assets	1,072	1,064	920.78	774.15	641	616.19
Accounts Payable	175.67	166.25	198.71	99.1	78.44	73.45
Accrued Expenses	26.46	19.73	17.29	15.19	14.6	12.45
Short-Term Debt	150.58	170.77	99.52	102.5	81.91	114.43
Current Portion of Long-Term Debt	26.18	11.68	57.67	3.14	4.99	4.84
Current Portion of Leases	11.68	12.85	11.17	8.25	7.97	6.8
Current Income Taxes Payable	-	2.32	0.81	1.17	0.51	0.02
Current Unearned Revenue	-	5.75	2.44	2.26	13.54	1.32
Other Current Liabilities	19.12	40.74	7.86	79.86	6.28	3.45
Total Current Liabilities	409.69	430.09	395.46	311.46	208.22	216.77
Long-Term Debt	59.73	69.13	33.14	28.87	14.19	21.94
Long-Term Leases	41.15	49.08	44.99	36.63	35.76	21.06
Long-Term Unearned Revenue	1.68	2.38	2.23	2.52	3.15	3.47
Pension & Post-Retirement Benefits	6	5.99	5.02	4.14	3.22	3.73
Long-Term Deferred Tax Liabilities	2.91	3.21	4.26	2.26	3.27	4.33
Other Long-Term Liabilities	11.73	1.73	3.5	2.96	6.86	7.97
Total Liabilities	532.88	561.61	488.6	388.84	274.68	279.26
Common Stock	274.97	275.8	91.81	88.24	68.9	68.93
Retained Earnings	208.5	206.07	340.17	301.66	295.07	259.89
Treasury Stock	-	-9.32	-27.45	-29.37	-26.68	-25.71
Comprehensive Income & Other	39.04	14.11	14.84	16.96	22.91	27.73
Total Common Equity	522.5	486.66	419.36	377.49	360.2	330.84
Minority Interest	16.59	15.56	12.81	7.82	6.12	6.08
Shareholders' Equity	539.09	502.23	432.18	385.31	366.32	336.93
Total Liabilities & Equity	1,072	1,064	920.78	774.15	641	616.19
Total Debt	289.32	313.5	246.49	179.38	144.81	169.07
Net Cash (Debt)	-267.18	-276.88	-228.19	-113.49	-134.66	-149.78
Net Cash Per Share	-0.52	-0.81	-0.46	-0.27	-0.36	-0.40
Filing Date Shares Outstanding	1,014	525.53	497.23	477.34	363.96	365.23
Total Common Shares Outstanding	1,014	525.53	497.23	477.34	363.96	365.23
Working Capital	154.75	127.65	39.93	90.94	84.42	75.35
Book Value Per Share	0.52	0.93	0.84	0.79	0.99	0.91
Tangible Book Value	394.22	356.54	284.64	346.17	333.79	296.15
Tangible Book Value Per Share	0.39	0.68	0.57	0.73	0.92	0.81
Land	-	201.96	193.01	26.19	30.8	31.14
Buildings	-	-	-	144.36	139.84	125.21
Machinery	-	162.21	152.84	144.95	142.66	137.95
Construction In Progress	-	12.72	9.06	3.62	2.82	2.45